Delivery Order SPE2DB24D2101-SPE2DB24FKGMF

Award Date 9/16/24
Potential Completion Date 10/7/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $3,404.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of VEKLURY 100 mg vials, with a performance period through March 26, 2024. The contract is a firm fixed-price award and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm fixed-price delivery order valued at $6,809.20. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,618.40, is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing type. It was awarded on August 28, 2024 and was not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VEKLURY 100 MG VIALS. The $10,213.80 contract has a completion date of February 29, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of a larger indefinite delivery contract with DLA valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VEKLURY 100 MG Vials, a pharmaceutical product, with a firm fixed price of $3,404.60 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite...
This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of VEKLURY 100 MG VIALS. The contract has a ceiling value of $6,809.20 and an ultimate completion date of September 10, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with extensive experience in providing critical care materials and a diverse range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,754.64 firm fixed-price delivery order contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGMF
    Delivery Order

This contract award is for the delivery of VEKLURY 100 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,702.30, is a Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific contract award is not designated as a set-aside.

Generated 12/16/24, 2:23 PM